Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
Abemaciclib for Liposarcoma
Recruiting3 awardsPhase 2
New York, New York
This trial is testing the effects of the drug Abemaciclib on cancer growth. Researchers hope to learn if the drug can delay cancer growth or shrink tumors. Abemaciclib is not FDA approved, but has shown promise in shrinking tumors in patients with breast cancer, lymphoma, and lung cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service